News & Insights | Informa Connect

This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

National Restaurant Association Show Reinforces Workforce Investment with 2026 Young Professionals Scholarship Program

Sanofi acquires Dynavax for $2.2bn, adding Hepatitis B vax and shingles candidate

Zejing’s DLL3 cancer drug goes global with AbbVie co-sign

Merck reportedly in talks to buy Revolution in huge $28–32bn deal

Rumor has it: Sanofi eyes higher bid for retinal drug developer

Double take: Novartis signs back-to-back licensing agreements

Eikon Therapeutics sets sights on public markets

Parabilis Medicines’ latest financing round causes IPO whispers

Medline targets $5.37bn in landmark IPO

Aktis Oncology sets sights on first IPO of 2026

Destinations Make the Most of America’s 250th Anniversary

Risk leadership report: CRO insights from RiskMinds International 2025

Small Towns Get a Big Push with Competition

Announcing Women in Comms Spotlight Winners and Future Leaders

Europe's biggest private credit hotspot is back!

Who will be at Private Placements Industry Forum 2026?

European private credit in 2026: Three questions LPs are asking

6 Destination Marketing Trends to Watch in 2026

Lisbon: Charting the New Course for European Life Sciences

The integration advantage: How Novartis unified its deal-making operations

Quick Links